Posted Sep 28, 2026

MedTech Advisory Board Member

Apply Now
About Pumpinheart 50% of advanced heart failure patients have HFpEF. Most have no effective treatment options. Existing therapies fail to address elevated left atrial pressure during diastole, the core driver of the disease. Patients are breathless at rest. Their prognosis is poor. And the MedTech industry has yet to solve it. Pumpinheart fixes this. Originating from research at the Royal College of Surgeons in Ireland (RCSI), Pumpinheart is developing the world's first transcatheter, implantable ECG-gated diastolic heart pump, a new category of minimally invasive mechanical circulatory support designed specifically for Advanced Stage HFpEF. The device is delivered via an outpatient cath-lab procedure, typically requiring just one overnight stay, and is designed to: Reduce left atrial pressure Improve cardiac filling Allow patients breathless at rest to breathe freely again Improve exercise tolerance and quality of life Extend life expectancy by many years Pumpinheart's foundation is built on deep cardiovascular research, advanced simulation, and early feasibility studies. The company is now preparing for expanded clinical validation and strategic partnerships across the U.S. and Europe. Key Milestones Originated from RCSI, one of the world's leading medical universities Accepted into Health Wildcatters 2025 Cohort, a top-ranked U.S. health tech accelerator First committed investor secured; active seed fundraising round underway Leadership team spans cardiothoracic surgery, medical physics, and serial entrepreneurship Non-executive board includes the CEO of Endowave and the CEO of ClinRe CRO / Associate Professor at the University of Houston Preparing for expanded clinical validation and first-in-human planning The Opportunity Pumpinheart is expanding its high-impact MedTech Advisory Board, bringing together leaders across medical devices, digital health, cardiovascular innovation, health system operations, and medtech commercialization. Advisors will play a critical role in positioning Pumpinheart for clinical and commercial success, ensuring our technology, workflows, and market strategy align with the realities of modern healthcare systems and medtech adoption. How You'll Contribute Clinical Workflow and Regulatory Advise on integration into HF, cardiology, and cath-lab workflows Provide input on clinical trial design, regulatory pathways, and endpoint selection Share insights on procedural workflow, device positioning, and clinical data requirements Go-to-Market and Strategic Connections Introduce Pumpinheart to health systems, heart failure programs, interventional cardiology leaders, and medtech partners Support expansion across priority U.S. and E.U. markets Advise on health system engagement, payer strategy, and market rollout sequencing Product and Market Insight Offer feedback on device usability, clinician experience, and procedural efficiency Advise on patient selection, outcomes measurement, and adoption barriers Provide insight on pricing strategy, reimbursement pathways, and commercial differentiation Apply If You Have at Least 3 of the Following 10+ years in health tech, medtech, cardiology innovation, or health system leadership Experience scaling medical devices, digital health platforms, or regulated technologies Expertise in reimbursement strategy, payer engagement, or value-based care Leadership experience within hospital systems, medtech companies, or enterprise healthcare organizations Strong networks across health systems, cardiovascular innovation, or medtech commercialization Passion for improving HFpEF outcomes and reducing the global burden of heart failure Compensation and Engagement Equity-based advisory compensation 1 to 2 hours per month, fully remote Access to internal strategy documents, clinical roadmap, and investor updates Option to participate in Pumpinheart's current or future funding rounds Advisors will receive early visibility into Pumpinheart's active fundraising round, with the opportunity to participate alongside clinicians, medtech leaders, and institutional supporters. Equal Opportunity Pumpinheart is committed to building a diverse, mission-aligned advisory board. We welcome professionals from all backgrounds and perspectives and are proud to be an equal opportunity organization.